-
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patientsZacharias M1, Joffe S, Goldberg RJ et al. -
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF TrialMN Kosiborod, PJhund, KF Docherty et al.
-
Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart FailureB Tayal, D Debs, F Nabi et al.
-
Heart Failure With Preserved Ejection Fraction in the YoungJ Tromp , MR MacDonald, CSP Lam et al.
-
Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart FailureJGE Zelt, RA deKemp, BH Rotstein et al.
-
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) StudyIbrahim NE, Januzzi JL Jr.
-
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart AssociationKonstam MA, Kiernan MS, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia.
-
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry studyA Ghimire, N Fine, FA McAlister et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
